Proliferation_index_in_various_stages_of_breast_cancer_determined_by_Ki-67_immunostaining._To_investigate_factors_involved_in_progression_of_breast_cancer,_we_estimated_the_growth_fraction_of_malignant_cell_populations_in_various_stages_of_mammary_cancer_growth._Frozen_sections_were_immunostained_with_the_Ki-67_monoclonal_antibody_and_the_proliferation_index_determined_using_static_image_analysis._Pure_intraductal_carcinoma,_intraductal_carcinoma_coexisting_with_invasive_disease,_and_metastatic_sites_coexisting_with_primary_tumors_were_studied._The_proliferation_index_of_pure_intraductal_carcinomas_(mean_4.5%,_median_1.8%)_was_not_significantly_different_from_invasive_mammary_cancers_(mean_5.1%,_median_2.2%)._The_proliferation_index_determined_for_the_in_situ_component_of_primary_cancers_(mean_3.8%,_median_1.5%)_was_not_significantly_different_from_values_obtained_from_the_invasive_component_of_growth_(mean_4.2%,_median_2.1%)._Variability_between_in_situ_and_invasive_components_for_individual_cases_was_minimal_in_tumors_whose_proliferation_index_was_less_than_3.0%;_for_tumors_with_higher_proliferation_indices,_the_differences_were_greater._However,_there_was_no_trend_toward_a_decrease_or_increase_in_growth_fraction_for_the_two_components_of_primary_tumor_growth._The_mean_proliferative_index_for_primary_tumors_(mean_4.9%,_median_4.0%)_was_not_significantly_different_from_the_mean_proliferative_score_from_a_matched_group_of_metastatic_sites_in_the_same_patients_(mean_5.7%,_median_5.5%)._Comparison_of_individual_cases_uncovered_differences_in_some_tumors;_again_no_consistent_trends_in_either_direction_were_noted._An_increase_(or_decrease)_in_growth_activity_does_not_accompany_the_transition_from_intraductal_(in_situ)_disease_to_invasive_mammary_cancer,_nor_does_a_change_in_growth_fraction_necessarily_accompany_progression_of_mammary_cancer_from_the_primary_to_regional_metastatic_site.